Valuation: Coral Laboratories Limited

Market Cap 132.38Cr 1.39Cr 1.2Cr 1.13Cr 1.03Cr 1.93Cr 1.96Cr 13Cr 5.18Cr 66Cr 5.21Cr 5.1Cr 221.03Cr P/E 2024
8.4x
P/E 2025 10.4x
Enterprise Value 104.99Cr 1.1Cr 95.37L 89.36L 81.51L 1.53Cr 1.56Cr 11Cr 4.11Cr 53Cr 4.13Cr 4.04Cr 175.3Cr EV / Sales 2024
1.25x
EV / Sales 2025 1.94x
Free-Float
19.97%
Yield 2024
0.54%
Yield 2025 0.21%
1 day-3.26%
1 week+0.39%
Current month-2.47%
1 month-7.35%
3 months+23.22%
6 months+14.48%
Current year+27.74%
1 week 540
Extreme 540
604.85
1 month 540
Extreme 540
615
Current year 360
Extreme 360
659
1 year 360
Extreme 360
659
3 years 251.1
Extreme 251.1
999
5 years 217
Extreme 217
999
10 years 81.2
Extreme 81.2
1,190
Manager TitleAgeSince
Director of Finance/CFO 49 26/05/2017
Director TitleAgeSince
Director/Board Member 45 26/05/2017
Director/Board Member 49 26/05/2017
Director/Board Member 40 28/05/2019
Change 5-day change 1-year change 3-year change Capi.($)
-3.26%+0.39%-2.07%+113.23% 2.14Cr
+0.43%+4.31%+90.84%+130.99% 1,08300Cr
+0.41%+1.27%+50.98%+50.05% 63TCr
-0.53%+1.04%+25.23%+63.46% 44TCr
-0.92%+0.22%+48.34%+37.85% 36TCr
-1.32%-0.21%+29.07%+36.81% 29TCr
-1.20%-2.78%+5.56%+6.09% 25TCr
+0.45%+2.05%+46.04%+58.54% 22TCr
-2.51%+1.77%-6.55%-51.74% 21TCr
+0.07%+3.12%+13.21%+69.84% 17TCr
Average -0.84%+1.32%+30.06%+51.51% 36.59TCr
Weighted average by Cap. -0.26%+2.19%+49.22%+65.96%

Financials

2024 2025
Net sales 84Cr 87.71L 76L 71.2L 64.95L 1.22Cr 1.24Cr 8.37Cr 3.27Cr 42Cr 3.29Cr 3.22Cr 139.68Cr 115.01Cr 1.21Cr 1.04Cr 97.88L 89.28L 1.68Cr 1.7Cr 12Cr 4.5Cr 58Cr 4.53Cr 4.43Cr 192.01Cr
Net income 16Cr 16.55L 14.34L 13.44L 12.26L 23.04L 23.4L 1.58Cr 61.78L 7.91Cr 62.15L 60.8L 26Cr 24Cr 25.33L 21.94L 20.56L 18.75L 35.25L 35.8L 2.42Cr 94.52L 12Cr 95.09L 93.02L 40Cr
Net Debt -28Cr -29.13L -25.24L -23.65L -21.57L -40.55L -41.18L -2.78Cr -1.09Cr -14Cr -1.09Cr -1.07Cr -46Cr -27Cr -28.72L -24.88L -23.31L -21.26L -39.97L -40.59L -2.74Cr -1.07Cr -14Cr -1.08Cr -1.05Cr -46Cr
Logo Coral Laboratories Limited
Coral Laboratories Limited is an India-based pharmaceutical company. The Company is engaged in the business of pharmaceutical formulations. The Company is engaged in the manufacturing of generic - branded, nutraceuticals, over the counter (OTC), and herbal medicines. It offers dosage forms, which include tablets, capsules, liquid orals, injections (liquids and powder), ointment and creams, gels and lotions, and suppositories. Its product categories include nutraceutical, OTC, sterile and non-sterile. Its nutraceutical products include DAX 200, DAX 400 Drops, Zest drops, and Super Zestcal Tablets. Its OTC products include herbal range, skin care, medical devices, and effervescent range. Its sterile products include small volume liquid - injectables, lyophilized range - injectables, eye drops, and eardrops. Its non-sterile antibiotics/antibacterials, antifungals, gastro-intestinal drugs, anti-emetics, and muscle relaxants. The Company also exports its products to various countries.
Employees
197
Date Price Change Volume
13/26/13 560.15 -3.26% 112
12/26/12 ₹579.05 +1.18% 837
11/26/11 ₹572.30 -0.97% 1,429
07/26/07 ₹577.90 +3.57% 583
06/26/06 ₹558.00 -0.76% 368
  1. Stock Market
  2. Stocks
  3. CORALAB6 Stock